Literature DB >> 32469943

Vancomycin and nisin A are effective against biofilms of multi-drug resistant Staphylococcus aureus isolates from human milk.

Angeliki Angelopoulou1,2, Des Field1,2, Mariana Pérez-Ibarreche2, Alicja K Warda2, Colin Hill1,2, R Paul Ross1,2.   

Abstract

Human milk provides complete nutrition for infants and at the same time promotes the growth of specific bacteria in the infant gastrointestinal tract. Breastfeeding can often be discontinued due to mastitis which is an inflammation of the breast tissue. We isolated 18 Staphylococcus aureus strains from milk donated by healthy (n = 6), subclinical (n = 6), and mastitic (n = 6) mothers, two strains of which were VISA (Vancomycin Intermediate S. aureus). All tested strains (n = 12) were able to form biofilms. We then examined the impact of nisin A and vancomycin alone and in combination on biofilm formation and eradication of selected strains (n = 8). We observed strain-specific responses, with the combinatorial treatment at 1/4X MIC (for both singularly) significantly inhibiting biofilm formation for seven out of eight strains when compared with nisin A or vancomycin alone. None of the selected treatments were able to eradicate pre-formed biofilms. Finally, we selected two strains, namely a VISA (APC3814H) and a strong biofilm former (APC3912CM) and used confocal microscopy to evaluate the effects of the antimicrobial agents at 1X MIC on biofilm inhibition and eradication. All treatments inhibited biofilm formation of APC3814H but were ineffective in eradicating a pre-formed biofilm. Single treatments at 1X MIC against APC3912CM cells did not prevent biofilm formation whereas combination treatment caused increased death of APC3912CM cells. Finally, the combination treatment reduced the thickness of the pre-formed APC3912CM biofilm as compared with the single treatments.

Entities:  

Year:  2020        PMID: 32469943     DOI: 10.1371/journal.pone.0233284

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  10 in total

Review 1.  Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens.

Authors:  Mi Nguyen-Tra Le; Miki Kawada-Matsuo; Hitoshi Komatsuzawa
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

2.  Biofilm-Forming Ability and Effect of Sanitation Agents on Biofilm-Control of Thermophile Geobacillus sp. D413 and Geobacillus toebii E134.

Authors:  Tugba Kİlİc
Journal:  Pol J Microbiol       Date:  2020-11-23

3.  Isolation, Characterization and Structure Elucidation of a Novel Lantibiotic From Paenibacillus sp.

Authors:  Jerzy Karczewski; Stephen P Krasucki; Papa Nii Asare-Okai; Carl Diehl; Andrew Friedman; Christine M Brown; Yukari Maezato; Stephen J Streatfield
Journal:  Front Microbiol       Date:  2020-11-24       Impact factor: 5.640

Review 4.  Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance.

Authors:  Sahaya Nadar; Tabassum Khan; Simon G Patching; Abdelwahab Omri
Journal:  Microorganisms       Date:  2022-01-27

5.  Influence of Fluoride-Resistant Streptococcus mutans Within Antagonistic Dual-Species Biofilms Under Fluoride In Vitro.

Authors:  Keke Zhang; Yangfan Xiang; Youjian Peng; Fengyu Tang; Yanfan Cao; Zhenjie Xing; Yejian Li; Xiangyan Liao; Yan Sun; Yan He; Qingsong Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-02-28       Impact factor: 5.293

Review 6.  Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances.

Authors:  Hassan Zgheib; Djamel Drider; Yanath Belguesmia
Journal:  Int J Environ Res Public Health       Date:  2020-10-26       Impact factor: 3.390

7.  Human milk microbiota in sub-acute lactational mastitis induces inflammation and undergoes changes in composition, diversity and load.

Authors:  Maria Carmen Collado; Alex Mira; Alba Boix-Amorós; Maria Teresa Hernández-Aguilar; Alejandro Artacho
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

8.  Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains.

Authors:  Désiré Madi-Moussa; Yanath Belguesmia; Audrey Charlet; Djamel Drider; Françoise Coucheney
Journal:  Antibiotics (Basel)       Date:  2021-12-24

9.  Influence of Nisin-Biogel at Subinhibitory Concentrations on Virulence Expression in Staphylococcus aureus Isolates from Diabetic Foot Infections.

Authors:  Carolina Jesus; Rui Soares; Eva Cunha; Miguel Grilo; Luís Tavares; Manuela Oliveira
Journal:  Antibiotics (Basel)       Date:  2021-12-07

10.  A Bioengineered Nisin Derivative To Control Streptococcus uberis Biofilms.

Authors:  Mariana Pérez-Ibarreche; Des Field; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.